A1-ADRENERGIC REGULATION OF CARDIAC GENE EXPRESSION
心脏基因表达的 A1-肾上腺素调节
基本信息
- 批准号:3360229
- 负责人:
- 金额:$ 24.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-07-01 至 1994-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This work is focused on the clinical problem of myocardial hypertrophy,
specifically the molecular mechanisms which regulate this process. A new
model system was developed to study hypertrophy, employing neonatal heart
myocytes in serum-free culture. The novel observation was made that
stimulation of the alpha 1-adrenergic receptor on these cells by the
catecholamine norepinephrine induces cell enlargement or hypertrophy,
without DNA synthesis. The alpha 1-adrenergic receptor is the first
receptor shown to regulate cardiac myocyte hypertrophy.
Recent work has shown that the alpha 1 receptor regulates mRNA expression
during hypertrophy. In particular, alpha 1 stimulation induces two
contractile protein iso-mRNAs characteristic of early cardiac development
and pressure-load hypertrophy in vivo, skeletal alpha-actin iso-mRNA and
B-myosin heavy chain iso-mRNA. This alpha 1 receptor effect is selective
and is mediated at the level of iso-gene transcription. Thus, the
critical question is the mechanism for induction of transcription by the
alpha 1 receptor.
The present experiments will test the hypothesis that the skeletal alpha-
actin iso-gene and the B-myosin heavy chain iso-gene contain one or more
alpha 1 response elements, i.e., DNA sequences required specifically for
transcription of these genes in response to alpha 1-adrenergic
stimulation.
Two complementary experimental approaches for functional identification
alpha 1 response elements are proposed: (1) transfection of hybrid genes
in a transient assay system; and (2) DNase I hypersensitivity mapping.
The necessary cloned genes are available to begin these experiments and
preliminary studies provide evidence that the work is feasible.
The long-range goal is to define the intracellular pathway from the alpha
1 receptor at the cell surface to gene transcription. The overall
hypothesis is that receptor stimulation activates a pre-existing protein
or proteins that binds to the alpha 1 response element in a
transcriptional complex with RNA polymerase II. Identification of an
alpha 1 response element or elements in the present work will provide the
foundation for subsequent identification of the protein or proteins.
本研究主要针对心肌肥厚的临床问题,
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAUL C SIMPSON其他文献
PAUL C SIMPSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAUL C SIMPSON', 18)}}的其他基金
Novel therapy for cardiotoxicity of cancer drugs
抗癌药物心脏毒性的新疗法
- 批准号:
8443184 - 财政年份:2012
- 资助金额:
$ 24.05万 - 项目类别:
Novel therapy for cardiotoxicity of cancer drugs
抗癌药物心脏毒性的新疗法
- 批准号:
8598801 - 财政年份:2012
- 资助金额:
$ 24.05万 - 项目类别:
Novel therapy for cardiotoxicity of cancer drugs
癌症药物心脏毒性的新疗法
- 批准号:
8760306 - 财政年份:2012
- 资助金额:
$ 24.05万 - 项目类别:
MYOCARDIAL RELAXATION AND CA++ TRANSPORT IN HYPERTROPHY
心肌肥厚时的心肌舒张和 CA 转运
- 批准号:
6151319 - 财政年份:1997
- 资助金额:
$ 24.05万 - 项目类别:
MYOCARDIAL RELAXATION AND CA++ TRANSPORT IN HYPERTROPHY
心肌肥厚时的心肌舒张和 CA 转运
- 批准号:
6351490 - 财政年份:1997
- 资助金额:
$ 24.05万 - 项目类别:
MYOCARDIAL RELAXATION AND CA++ TRANSPORT IN HYPERTROPHY
心肌肥厚时的心肌舒张和 CA 转运
- 批准号:
2872927 - 财政年份:1997
- 资助金额:
$ 24.05万 - 项目类别:
ALPHA-1 ADRENERGIC REGULATION OF CARDIAC GENE EXPRESSION
心脏基因表达的 ALPHA-1 肾上腺素调节
- 批准号:
2220319 - 财政年份:1989
- 资助金额:
$ 24.05万 - 项目类别:
A1-ADRENERGIC REGULATION OF CARDIAC GENE EXPRESSION
心脏基因表达的 A1-肾上腺素调节
- 批准号:
3360227 - 财政年份:1989
- 资助金额:
$ 24.05万 - 项目类别:
A1-ADRENERGIC REGULATION OF CARDIAC GENE EXPRESSION
心脏基因表达的 A1-肾上腺素调节
- 批准号:
3360228 - 财政年份:1989
- 资助金额:
$ 24.05万 - 项目类别:
相似海外基金
MOLECULAR BASIS OF ALPHA ADRENERGIC RECEPTOR FUNCTION
α 肾上腺素能受体功能的分子基础
- 批准号:
6110455 - 财政年份:1999
- 资助金额:
$ 24.05万 - 项目类别:
MOLECULAR BASIS OF ALPHA ADRENERGIC RECEPTOR FUNCTION
α 肾上腺素能受体功能的分子基础
- 批准号:
6273039 - 财政年份:1998
- 资助金额:
$ 24.05万 - 项目类别:
MOLECULAR BASIS OF ALPHA ADRENERGIC RECEPTOR FUNCTION
α 肾上腺素能受体功能的分子基础
- 批准号:
6242449 - 财政年份:1997
- 资助金额:
$ 24.05万 - 项目类别:
Central and renal alpha-adrenergic receptor with the development of salt-induced hypertension in Dahl-Iwai salt-sensitive rats.
中枢和肾脏 α-肾上腺素能受体与 Dahl-Iwai 盐敏感大鼠中盐诱导高血压的发展。
- 批准号:
03670461 - 财政年份:1991
- 资助金额:
$ 24.05万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
IDENTIFICATION AND FUNCTION OF ALPHA-ADRENERGIC RECEPTOR
α-肾上腺素能受体的鉴定和功能
- 批准号:
3079007 - 财政年份:1983
- 资助金额:
$ 24.05万 - 项目类别: